澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LUMOS DIAGNOSTICS HOLDINGS L

0.105

+0.0055.00%

成交量：135.29萬

成交額：14.14萬

市值：9,916.09萬

市盈率：-6.19

高：0.105

開：0.105

低：0.100

收：0.100

52周最高：0.330

52周最低：0.076

股本：9.44億

流通股本：3.76億

量比：3.00

換手率：0.36%

股息：- -

股息率：- -

每股收益(TTM):-0.017

每股收益(LYR):-0.015

淨資產收益率：-123.27%

總資產收益率：-29.18%

市淨率：13.61

市盈率(LYR):-7.14

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Lumos Diagnostics 2026財年營收增長6%，達1320萬美元

Lumos Diagnostics Holdings 尋求交易暫停，等待FDA對Febridx CLIA豁免申請的回應更新

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/LDX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.105,"timestamp":1787724720000,"preClose":0.1,"halted":0,"volume":1352876,"delay":0,"changeRate":0.049999999999999906,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":944389135,"eps":-0.016972314121539267,"marketStatus":"已收盤","change":0.005,"latestTime":"08-26 16:12:00 AEST","open":0.105,"high":0.105,"low":0.1,"amount":141386,"amplitude":0.05,"askPrice":0.105,"askSize":103404,"bidPrice":0.1,"bidSize":1177895,"shortable":3,"etf":0,"ttmEps":-0.016972314121539267,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.1,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":3.00361,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.1,"auctionPrice":0.105,"auctionVolume":255255,"auctionTime":1787724613171,"referencePrice":0.105,"referenceTime":1787734800825,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724613171}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-29.18%","roe":"-123.27%","lyrEps":-0.01471,"volumeRatio":3.00361,"shares":944389135,"dividePrice":0,"high":0.105,"amplitude":0.05,"preClose":0.1,"low":0.1,"week52Low":0.076,"pbRate":"13.61","psRate":"5.83","week52High":0.33,"institutionHeld":0,"latestPrice":0.105,"committee":0.838595,"eps":-0.016972314121539267,"divideRate":0,"volume":1352876,"delay":0,"ttmEps":-0.016972314121539267,"open":0.105,"prevYearClose":0.285,"prevWeekClose":0.105,"prevMonthClose":0.1,"prevQuarterClose":0.105,"fiveDayClose":0.105,"twentyDayClose":0.1,"sixtyDayClose":0.105,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-27","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785110400000,"name":null,"time":"","dateTimestamp":1785074400000,"actualEps":null},{"date":"2026-04-20","symbol":"LDX.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"盤後","dateTimestamp":1776607200000,"actualEps":null},{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134059989","title":"Lumos Diagnostics 2026財年營收增長6%，達1320萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134059989","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134059989?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 09:42","pubTimestamp":1785116568,"startTime":"0","endTime":"0","summary":"在2026财年，Lumos Diagnostics Holdings Ltd（LUMOS DIAGNOSTICS HOLDINGS L）交出了一份亮眼的成绩单。公司营业收入同比攀升6%，总额达到1320万美元。这一数据，不仅反映了其在诊断领域的持续深耕，也彰显了市场对其产品的强劲需求。从财务表现来看，稳健的增长势头为这家企业注入了更多信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128307929","title":"Lumos Diagnostics Holdings 尋求交易暫停，等待FDA對Febridx CLIA豁免申請的回應更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128307929","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128307929?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390934,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings（ASX: LDX）已向澳大利亚证券交易所申请交易暂停，以待公司就美国食品药品监督管理局（FDA）对其Febridx检测产品CLIA豁免申请的回应发布最新消息。\n该交易暂停将自2023年10月11日开盘时生效，直至公司发布相关公告或10月13日开盘时终止，以较早者为准。此举旨在确保在重要监管信息发布前，市场交易的公平性和有序性。\nFebridx是公司开发的一款快速诊断产品，CLIA豁免意味着该产品可在更广泛的医疗点（如诊所、药房）由非专业人员使用，从而显著扩大其市场潜力。此次FDA的回应对于该产品在美国的商业化进程至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LDX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}